These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 24051688)

  • 21. Functional interaction sites of OprM with MexAB in the Pseudomonas aeruginosa multidrug efflux pump.
    Yoshihara E; Eda S; Kaitou S
    FEMS Microbiol Lett; 2009 Oct; 299(2):200-4. PubMed ID: 19709308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between antibiotic use and incidence of MexXY-OprM overproducers among clinical isolates of Pseudomonas aeruginosa.
    Hocquet D; Muller A; Blanc K; Plésiat P; Talon D; Monnet DL; Bertrand X
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1173-5. PubMed ID: 18180356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro transport activity of the fully assembled MexAB-OprM efflux pump from Pseudomonas aeruginosa.
    Verchère A; Dezi M; Adrien V; Broutin I; Picard M
    Nat Commun; 2015 Apr; 6():6890. PubMed ID: 25901994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of MexAB-OprM in intrinsic resistance of Pseudomonas aeruginosa to temocillin and impact on the susceptibility of strains isolated from patients suffering from cystic fibrosis.
    Buyck JM; Guénard S; Plésiat P; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Mar; 67(3):771-5. PubMed ID: 22218683
    [No Abstract]   [Full Text] [Related]  

  • 25. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assignment of the outer-membrane-subunit-selective domain of the membrane fusion protein in the tripartite xenobiotic efflux pump of Pseudomonas aeruginosa.
    Eda S; Maseda H; Yoshihara E; Nakae T
    FEMS Microbiol Lett; 2006 Jan; 254(1):101-7. PubMed ID: 16451186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new member of the tripartite multidrug efflux pumps, MexVW-OprM, in Pseudomonas aeruginosa.
    Li Y; Mima T; Komori Y; Morita Y; Kuroda T; Mizushima T; Tsuchiya T
    J Antimicrob Chemother; 2003 Oct; 52(4):572-5. PubMed ID: 12951344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3322-7. PubMed ID: 11083635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of the Pseudomonas aeruginosa PlcH Tat signal peptide in protein secretion, transcription, and cross-species Tat secretion system compatibility.
    Snyder A; Vasil AI; Zajdowicz SL; Wilson ZR; Vasil ML
    J Bacteriol; 2006 Mar; 188(5):1762-74. PubMed ID: 16484187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
    Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. oprM as a new target for reversion of multidrug resistance in Pseudomonas aeruginosa by antisense phosphorothioate oligodeoxynucleotides.
    Wang H; Meng J; Jia M; Ma X; He G; Yu J; Wang R; Bai H; Hou Z; Luo X
    FEMS Immunol Med Microbiol; 2010 Dec; 60(3):275-82. PubMed ID: 20955466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macrolide antibiotic-mediated downregulation of MexAB-OprM efflux pump expression in Pseudomonas aeruginosa.
    Sugimura M; Maseda H; Hanaki H; Nakae T
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4141-4. PubMed ID: 18676884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased susceptibility of Pseudomonas aeruginosa to macrolides and ketolides in eukaryotic cell culture media and biological fluids due to decreased expression of oprM and increased outer-membrane permeability.
    Buyck JM; Plésiat P; Traore H; Vanderbist F; Tulkens PM; Van Bambeke F
    Clin Infect Dis; 2012 Aug; 55(4):534-42. PubMed ID: 22573850
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the drug discharge outer membrane protein, OprM, of Pseudomonas aeruginosa: dual modes of membrane anchoring and occluded cavity end.
    Akama H; Kanemaki M; Yoshimura M; Tsukihara T; Kashiwagi T; Yoneyama H; Narita S; Nakagawa A; Nakae T
    J Biol Chem; 2004 Dec; 279(51):52816-9. PubMed ID: 15507433
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interplay between the efflux pump and the outer membrane permeability barrier in fluorescent dye accumulation in Pseudomonas aeruginosa.
    Germ M; Yoshihara E; Yoneyama H; Nakae T
    Biochem Biophys Res Commun; 1999 Aug; 261(2):452-5. PubMed ID: 10425205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of the MexX-MexY-oprM efflux system to intrinsic resistance in Pseudomonas aeruginosa.
    Masuda N; Sakagawa E; Ohya S; Gotoh N; Tsujimoto H; Nishino T
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2242-6. PubMed ID: 10952562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome-Wide Transposon Screen of a
    Helmann TC; Ongsarte CL; Lam J; Deutschbauer AM; Lindow SE
    mBio; 2019 Oct; 10(5):. PubMed ID: 31662463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Directed evolution of a bacterial efflux pump: adaptation of the E. coli TolC exit duct to the Pseudomonas MexAB translocase.
    Bokma E; Koronakis E; Lobedanz S; Hughes C; Koronakis V
    FEBS Lett; 2006 Oct; 580(22):5339-43. PubMed ID: 16979625
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.